Dow Jones Futures Fall As Nike Dives; Apple Leads Six Stocks To Watch With Inflation Data Due


Dow Jones futures fell slightly overnight, while S&P 500 futures and Nasdaq futures edged lower. Nike (NKE) plunged on mixed earnings late. The Fed’s favorite inflation gauge headlines Friday economic data.




X



The stock market rally rebounded Thursday, with the indexes trading within the range of Wednesday’s violent sell-off.

AAPL stock edged lower, holding just above a buy point. As expected. Apple (AAPL) stopped sales of some Apple Watch models due to a patent dispute. Carnival Corp. (CCL) cleared an early buy point on earnings. Google parent Alphabet (GOOGL) reclaimed a buy point. Microsoft (MSFT) is holding in a buy zone. Novo Nordisk (NVO) is moving toward a buy point while Super Micro Computer (SMCI) appears to be working on a handle.

Overall buying opportunities are limited. Generally, it’s a time to be holding steady, perhaps taking some partial profits, while awaiting the market’s next move.

MSFT stock is on IBD Leaderboard. CCL stock is on SwingTrader. Microsoft stock is on IBD Long-Term Leaders. Carnival, Super Micro and NVO stock are on the IBD 50. Carnival also was Thursday’s IBD Stock Of The Day.

Dow Jones Futures Today

Dow Jones futures fell 0.2% vs. fair value, with NKE stock a modest drag. S&P 500 futures declined 0.1% and Nasdaq 100 futures declined 0.3%.

Crude oil futures edged higher.

The PCE inflation readings and other economic data before the open will be sure to swing Dow futures and Treasury yields before the open.

Remember that overnight action in Dow futures and elsewhere doesn’t necessarily translate into actual trading in the next regular stock market session.

Nike Earnings

NKE stock fell sharply overnight as Nike earnings topped views while revenue was in line. The Dow Jones apparel and shoe giant slashed its sales forecast and announced a big cost-cutting plan. Nike stock advanced 0.9% to 122.53 on Thursday, still building the right side of a long cup base. Shares have a 131.31 buy point.

PCE Inflation

The November PCE price index is due Friday at 8:30 a.m. ET. Economists expect a 0.1% decline vs. October, with the yearly gain nudging down to 2.9%. The core PCE price index, the Fed’s favorite inflation measure, is seen rising 0.2% on the month. Core PCE inflation should tick down to 3.4%.

The PCE price index is part of the Commerce Department’s income and spending report. Personal income is forecast to climb 0.4% with spending up 0.3%.

Commerce will release the durable goods orders at the same time. Overall orders are seen bouncing 2.4% after October’s 5.4% tumble. Orders excluding transportation items should rise 0.2% after a flat October. Core capital goods orders are seen edging up 0.1% after October’s 0.3% decline.

At 10 a.m. ET, new-home sales are expected to show a slight November gain to an annual rate of 690,000 from October’s 679,000.


Join IBD experts as they analyze leading stocks and the market on IBD Live


Stock Market Rally

After Wednesday’s sharp, downside reversal, the expectation was that selling would continue. But this market doesn’t want to pull back, rebounding Thursday and closing at session highs.

The Dow Jones Industrial Average climbed 0.9% in Thursday’s stock market trading. The S&P 500 index bounced 1%. The Nasdaq composite jumped 1.3%. The small-cap Russell 2000 leapt 1.7%.

For all these indexes, it was an inside day, trading comfortably within Wednesday’s range. So it’s hard to take too much meaning from Thursday’s action. Perhaps the market will pause or pullback modestly over several days or sessions. That could be ideal, letting the indexes catch their breath and allow leading stocks to forge new buying opportunities.

This is a natural place for the indexes to pause. The S&P 500 is just below record highs. The Nasdaq is trading around the 15,000 level and is still somewhat extended from the 50-day line. The Russell 2000 is hitting resistance just above the 2,000 level.

U.S. crude oil prices dipped 0.4% to $73.89 a barrel.

The 10-year Treasury yield edged higher to 3.89% after falling as low as 3.83%.

ETFs

Among growth ETFs, the iShares Expanded Tech-Software Sector ETF (IGV) climbed 1.4%, with MSFT stock a major component. The VanEck Vectors Semiconductor ETF (SMH) leapt 2.5%.

Reflecting more-speculative story stocks, ARK Innovation ETF (ARKK) bounced 2.55% and ARK Genomics ETF (ARKG) gained 3%.

SPDR S&P Metals & Mining ETF (XME) rose 2.3%. U.S. Global Jets ETF (JETS) ascended 2%. SPDR S&P Homebuilders ETF (XHB) climbed 1.4%. The Energy Select SPDR ETF (XLE) edged up 0.4% and the Health Care Select Sector SPDR Fund (XLV) advanced 1.2%,

The Industrial Select Sector SPDR Fund (XLI) and Financial Select SPDR ETF (XLF) both bounced 1%.


Microsoft’s Cybersecurity Business Is Booming. Critics Say It’s The Problem.


Apple Stock

Apple stock dipped 0.1% to 194.68, holding above a 192.93 cup-with-handle buy point with a rising 21-day moving average just below that. As expected, Apple stopped selling its Apple Watch Series 9 and Ultra 2 on its U.S. website. That follows orders from the International Trade Commission, which found that those Apple Watch models’ blood oxygen sensor infringes intellectual property rights of Masimo (MASI). That means Apple isn’t selling key consumer products in the final days of the holiday season.

Stocks Near Buy Points

Carnival stock jumped 6,2% to 19.19 on Thursday. Shares nearly hit a 19.55 cup-base buy point, according to MarketSmith analysis. Investors could use the Dec. 14 high of 19.23 as an early entry from a not-quite handle. Early Thursday, Carnival reported a smaller-than-expected loss while reporting strong revenue and guidance.

Google stock rose 1.5% to 140.42, above a 139.42 cup-with-handle buy point. Shares broke out Wednesday morning on a report of a possible ad sales revamp, but slashed gains in Wednesday’s sell-off. The relative strength line has lagged for the past two months, but has started picking up again.

Microsoft stock edged up 0.8% to 373.54, continuing to hug the 21-day moving average as the 50-day line closes the gap. Shares are still holding in range from a 366.78 cup-base buy point, first cleared on Nov. 10. Investors might want to wait for MSFT stock to clear a short trendline, using Wednesday’s high of 376.03 as a specific entry.

Novo Nordisk stock climbed 2.1% to 103.48. Shares are close to retaking a prior 104 buy point from a flat base, though that’s technically no longer valid. NVO stock could be working on a new flat base, which would have a 105.69 entry. Novo Nordisk has strengthened over the past two weeks, while weight-loss drug rival Eli Lilly (LLY) is stuck below the 50-day.

Super Micro stock edged up 0.7% to 304.18, fading from intraday highs. The AI server play appears to be working on a handle right around key levels after a strong five-day rally. SMCI stock is tightening up after some wild swings earlier in the consolidation.

What To Do Now

The stock market rally is still solidly intact. But there aren’t many buying opportunities while the very short-term market trend is unclear following Wednesday’s reversal. It’s good to game out potential scenarios, but ultimately you need to take the market day by day.

Investors might want to take some profits, but a lot will depend on your current holdings and your investing style. There are plenty of reasons to remain heavily invested.

Keep working on watchlists for developing setups. Leading stocks could quickly form handles or bullish pullbacks if the market takes a breather.

Read The Big Picture every day to stay in sync with the market direction and leading stocks and sectors.

Please follow Ed Carson on X/Twitter at @IBD_ECarson, Threads at @edcarson1971 and Bluesky at @edcarson.bsky.social for stock market updates and more.

YOU MAY ALSO LIKE:

Best Growth Stocks To Buy And Watch

IBD Digital: Unlock IBD’s Premium Stock Lists, Tools And Analysis Today

Time The Market With IBD’s ETF Market Strategy



Signup bonus from $125 to $3000 | Signup now Football & Online Casino

0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

You Might Also Like: